药物涂层气球用于早期复发的动脉静脉瘤功能障碍
Chun-Hsien Hsin1, Hsuan-Tzu Yang1, Pin-Chao Feng1
1Division of Thoracic and Cardiovascular Surgery, Department of Surgery, Chang Gung Memorial Hospital, Taoyuan, Linkou.
The journal of vascular access
|June 13, 2023
概括
兰杰药物涂层气球 (DCB) 有效地治疗功能失调的动脉静脉 (AVF),在6个月内显示68%的通透率. 这种治疗特别有利于早期复发的AVF狭窄,显著改善了结果.
科学领域:
- 血管外科 血管外科
- 干预性病学 干预性病学
- 医疗器械 医疗器械
背景情况:
- 功能失调的自身动脉静脉 (AVFs) 在血液透析上构成了重大挑战.
- 结节症是一种常见的并发症,导致通病率降低和发病率增加.
- 药物涂层气球 (DCB) 提供了一个潜在的治疗选择,以改善AVF干预的结果.
研究的目的:
- 评估Ranger药物涂层气球 (DCB) 的疗效和安全性,用于治疗功能失调的自身AVF.
- 在6个月后评估目标病变初级通透率的初级终点.
- 确定二次结果,包括解剖/临床成功和不良事件.
主要方法:
- 对25名患有功能障碍的AVF的参与者进行前性观察队列研究.
- 在高压气球血管整形术后用于容器准备的Ranger DCB应用.
- 主要终点:目标病变6个月的初级通透率;次要:12个月的通透率,成功率和不良事件.
主要成果:
- 目标病变的初级通透率在6个月后为68%.
- 解剖学和临床成功率为100%.
- 在DCB血管整形中,早期复发性狭窄症的初级通透性日显著改善 (p < 0.001).
结论:
- 兰杰DCB是一种安全有效的治疗狭窄的AVFs.
- 该设备在管理早期复发的AVF狭窄症方面表现出特别的好处.
- 进一步的研究可能会探索长期的结果和更广泛的应用.
相关概念视频
Hemodialysis I: Introduction
69
Hemodialysis (HD) is a medical treatment that artificially removes waste products, excess fluids, and toxins from the blood when the kidneys are no longer able to perform these functions effectively. In this process, blood is filtered through a semipermeable membrane, allowing for the selective removal of waste while preserving necessary components like blood cells and proteins. Hemodialysis is typically performed in patients with end-stage renal disease (ESRD) or severe kidney...
69
Peripheral Artery Disease III: Interprofessional Care
13
Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
13
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
221
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
221
Venous Thrombosis III: Interprofessional Care
11
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
11


